Tsuji T, Naito K, Inoue J, Tsuchiya M, Araki K, Shinohara T, Onoue K, Nagashima H, Tokuyama K, Okada T
Acta Med Okayama. 1979 Apr;33(2):121-31.
A study of 52 liver biopsies (47 hepatitis type B and 5 asymptomatic carriers) was performed to clarify the roles of HBe antigen (HBeAg), HB surface antigen (HBsAg) and HB core antigen (HBcAg). In this study, the Gudat classification was modified so as to classify the patterns of HB antigens into six reaction types including: type O (negative for both liver HBsAg and liver HBcAg), type III-A (characterized by a spotty HBsAg pattern) and type III-B (characterized from a sub-lobular to lobular HBsAg localization pattern). This classification enabled accurate prediction of the prognosis of hepatitis. Patients with positive serum HBeAg had either minimal hepatitis with mild clinical features or chronic aggressive hepatitis with severe clinical features. Ten patients negative for both HBeAg and HBeAb were all positive for liver HBcAg. In all 3 patients on corticosteroid administrations liver tissue was markedly positive for HBcAg and serum was usually positive for HBeAb.
对52份肝活检样本(47例乙型肝炎患者和5例无症状携带者)进行了研究,以阐明HBe抗原(HBeAg)、HB表面抗原(HBsAg)和HB核心抗原(HBcAg)的作用。在本研究中,对古达分类法进行了修改,以便将HB抗原模式分为六种反应类型,包括:O型(肝HBsAg和肝HBcAg均为阴性)、III-A型(特征为斑点状HBsAg模式)和III-B型(特征为从亚小叶到小叶的HBsAg定位模式)。这种分类能够准确预测肝炎的预后。血清HBeAg阳性的患者要么是具有轻微临床特征的轻度肝炎,要么是具有严重临床特征的慢性侵袭性肝炎。10例HBeAg和HBeAb均为阴性的患者肝HBcAg均为阳性。在所有3例接受皮质类固醇治疗的患者中,肝组织HBcAg明显阳性,血清HBeAb通常为阳性。